Lirentelimab
Lirentelimab (AK002) is a humanized anti-sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) antibody that induces apoptosis of IL-5-activated eosinophils and inhibits IL-5-mediated mast cell activation, and is used in the study of refractory inert systemic mastocytosis and allergic conjunctivitis.
Product Specifications
CAS Number
2283348-97-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Apoptosis
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Human ANXA1 Matched Antibody Pair Set [ABP-Q-0328]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
248942-ML550 100 µL
MSH2 (mutS Homolog 2, Colon Cancer, nonpolyposis Type 1 (E. coli), COCA1, FCC1, HNPCC, HNPCC1, LCFS2) (MaxLight 550)
Ask
View Details N0555-04E-ML550 100 µL
NCOR1, CT (Nuclear Receptor Co-repressor 1, N-CoR, KIAA1047) (MaxLight 550) discontinued
Ask
View Details 